Free Trial

FibroBiologics (FBLG) Competitors

FibroBiologics logo
$1.12 -0.12 (-9.27%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$1.13 +0.00 (+0.44%)
As of 02/21/2025 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FBLG vs. LYEL, HURA, ZNTL, NLTX, CRGX, VXRT, ACRV, CDTX, ALEC, and ACRS

Should you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include Lyell Immunopharma (LYEL), TuHURA Biosciences (HURA), Zentalis Pharmaceuticals (ZNTL), Neoleukin Therapeutics (NLTX), CARGO Therapeutics (CRGX), Vaxart (VXRT), Acrivon Therapeutics (ACRV), Cidara Therapeutics (CDTX), Alector (ALEC), and Aclaris Therapeutics (ACRS). These companies are all part of the "pharmaceutical products" industry.

FibroBiologics vs.

FibroBiologics (NASDAQ:FBLG) and Lyell Immunopharma (NASDAQ:LYEL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation, community ranking and profitability.

66.1% of Lyell Immunopharma shares are held by institutional investors. 20.8% of FibroBiologics shares are held by insiders. Comparatively, 25.1% of Lyell Immunopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Lyell Immunopharma received 5 more outperform votes than FibroBiologics when rated by MarketBeat users. However, 100.00% of users gave FibroBiologics an outperform vote while only 48.28% of users gave Lyell Immunopharma an outperform vote.

CompanyUnderperformOutperform
FibroBiologicsOutperform Votes
9
100.00%
Underperform Votes
No Votes
Lyell ImmunopharmaOutperform Votes
14
48.28%
Underperform Votes
15
51.72%

In the previous week, Lyell Immunopharma had 1 more articles in the media than FibroBiologics. MarketBeat recorded 2 mentions for Lyell Immunopharma and 1 mentions for FibroBiologics. FibroBiologics' average media sentiment score of 0.00 equaled Lyell Immunopharma'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FibroBiologics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Lyell Immunopharma
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

FibroBiologics presently has a consensus target price of $13.00, indicating a potential upside of 1,055.56%. Lyell Immunopharma has a consensus target price of $1.00, indicating a potential upside of 42.71%. Given FibroBiologics' stronger consensus rating and higher probable upside, equities research analysts clearly believe FibroBiologics is more favorable than Lyell Immunopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FibroBiologics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Lyell Immunopharma
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

FibroBiologics has a net margin of 0.00% compared to Lyell Immunopharma's net margin of -323,792.09%. FibroBiologics' return on equity of 0.00% beat Lyell Immunopharma's return on equity.

Company Net Margins Return on Equity Return on Assets
FibroBiologicsN/A N/A -225.34%
Lyell Immunopharma -323,792.09%-34.64%-30.02%

FibroBiologics has higher earnings, but lower revenue than Lyell Immunopharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FibroBiologicsN/AN/A-$16.49MN/AN/A
Lyell Immunopharma$130K1,574.74-$234.63M-$0.79-0.89

Summary

FibroBiologics beats Lyell Immunopharma on 8 of the 14 factors compared between the two stocks.

Get FibroBiologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBLG vs. The Competition

MetricFibroBiologicsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$45.15M$7.07B$5.85B$9.15B
Dividend YieldN/A2.76%4.76%3.85%
P/E RatioN/A2.5616.5114.19
Price / SalesN/A304.55450.0276.60
Price / CashN/A65.6738.0134.95
Price / Book28.136.717.644.63
Net Income-$16.49M$138.11M$3.18B$245.69M
7 Day Performance-8.54%-2.54%-1.95%-2.68%
1 Month Performance-33.43%-2.00%-0.23%-2.16%
1 Year Performance-90.70%-5.04%16.69%12.90%

FibroBiologics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBLG
FibroBiologics
2.2572 of 5 stars
$1.13
-9.3%
$13.00
+1,055.6%
-90.9%$45.15MN/A0.0010
LYEL
Lyell Immunopharma
2.1946 of 5 stars
$0.61
+4.8%
$1.00
+63.9%
-69.3%$178.25M$63,000.00-0.77270Upcoming Earnings
Gap Up
HURA
TuHURA Biosciences
N/A$4.19
-8.5%
$13.00
+210.3%
N/A$177.15MN/A0.00N/ANews Coverage
ZNTL
Zentalis Pharmaceuticals
1.9069 of 5 stars
$2.43
flat
$8.24
+239.3%
-83.0%$173.16MN/A-0.98160Gap Up
NLTX
Neoleukin Therapeutics
N/A$18.42
-1.9%
N/A-41.9%$173.11MN/A-5.9290News Coverage
High Trading Volume
CRGX
CARGO Therapeutics
3.1068 of 5 stars
$3.70
+0.3%
$15.00
+305.4%
-82.7%$170.30MN/A-0.87116Gap Up
VXRT
Vaxart
1.5405 of 5 stars
$0.75
-0.9%
$4.00
+436.0%
-49.4%$169.75M$7.38M-1.82120
ACRV
Acrivon Therapeutics
2.3269 of 5 stars
$5.42
+1.1%
$23.67
+336.7%
+45.8%$168.78MN/A-2.0158Short Interest ↓
CDTX
Cidara Therapeutics
3.9216 of 5 stars
$23.94
+2.6%
$32.20
+34.5%
+55.6%$168.78M$63.90M-0.9490
ALEC
Alector
4.0749 of 5 stars
$1.70
+1.8%
$3.75
+120.6%
-69.9%$166.48M$97.06M-1.00270Upcoming Earnings
ACRS
Aclaris Therapeutics
2.2437 of 5 stars
$2.33
+5.9%
$11.00
+372.1%
+87.1%$166.43M$31.25M-4.48100

Related Companies and Tools


This page (NASDAQ:FBLG) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners